Financials Hancom Lifecare Inc.

Equities

A372910

KR7372910000

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-07-08 pm EDT 5-day change 1st Jan Change
4,885 KRW +0.83% Intraday chart for Hancom Lifecare Inc. -1.31% +7.72%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 161,895 125,503 135,189 - -
Enterprise Value (EV) 2 161.9 110 70.99 60.99 49.39
P/E ratio - 151 x 13.9 x 13.2 x 10.3 x
Yield - - - - -
Capitalization / Revenue 1.62 x 1.1 x 1.04 x 0.92 x 0.81 x
EV / Revenue 1.62 x 0.97 x 0.54 x 0.42 x 0.3 x
EV / EBITDA - 12.3 x 3.62 x 2.93 x 1.99 x
EV / FCF - -8.11 x 1.47 x 6.1 x 4.29 x
FCF Yield - -12.3% 68.2% 16.4% 23.3%
Price to Book - 0.98 x 0.91 x 0.85 x 0.79 x
Nbr of stocks (in thousands) 27,674 27,674 27,674 - -
Reference price 3 5,850 4,535 4,845 4,845 4,845
Announcement Date 3/15/23 1/22/24 - - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 100.1 113.6 130.3 146.5 166.8
EBITDA 1 - 8.916 19.6 20.8 24.8
EBIT 1 - 2.562 12.6 14 18
Operating Margin - 2.26% 9.67% 9.56% 10.79%
Earnings before Tax (EBT) 1 - 1.545 12.6 13.3 17.1
Net income 1 9.204 1.616 8.9 9.4 12
Net margin 9.19% 1.42% 6.83% 6.42% 7.19%
EPS 2 - 30.00 348.0 366.0 470.0
Free Cash Flow 3 - -13,550 48,400 10,000 11,500
FCF margin - -11,928.77% 37,145.05% 6,825.94% 6,894.48%
FCF Conversion (EBITDA) - - 246,938.78% 48,076.92% 46,370.97%
FCF Conversion (Net income) - - 543,820.22% 106,382.98% 95,833.33%
Dividend per Share - - - - -
Announcement Date 3/15/23 1/22/24 - - -
1KRW in Billions2KRW3KRW in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 48.08 13.64 35.9 27 53.8
EBITDA - - - - -
EBIT 1 0.121 -0.847 3.8 3.3 6.5
Operating Margin 0.25% -6.21% 10.58% 12.22% 12.08%
Earnings before Tax (EBT) 1 -1.189 -0.2125 3.6 3.1 6.1
Net income 1 1.684 -0.3862 2.6 2.2 4.4
Net margin 3.5% -2.83% 7.24% 8.15% 8.18%
EPS - - - - -
Dividend per Share - - - - -
Announcement Date 1/22/24 5/13/24 - - -
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - - - - -
Net Cash position 1 - 15.6 64.2 74.2 85.8
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 2 - -13,550 48,400 10,000 11,500
ROE (net income / shareholders' equity) - 1.26% 6.8% 6.7% 7.9%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 3 - 4,637 5,319 5,685 6,155
Cash Flow per Share - - - - -
Capex 1 - 5.08 4.9 5.5 6.3
Capex / Sales - 4.48% 3.76% 3.75% 3.78%
Announcement Date 3/15/23 1/22/24 - - -
1KRW in Billions2KRW in Million3KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A372910 Stock
  4. Financials Hancom Lifecare Inc.